<?xml version='1.0' encoding='utf-8'?>
<document id="28130915"><sentence text="Multiscale modeling reveals inhibitory and stimulatory effects of caffeine on acetaminophen-induced toxicity in humans."><entity charOffset="66-74" id="DDI-PubMed.28130915.s1.e0" text="caffeine" /><entity charOffset="78-91" id="DDI-PubMed.28130915.s1.e1" text="acetaminophen" /><pair ddi="false" e1="DDI-PubMed.28130915.s1.e0" e2="DDI-PubMed.28130915.s1.e0" /><pair ddi="false" e1="DDI-PubMed.28130915.s1.e0" e2="DDI-PubMed.28130915.s1.e1" /></sentence><sentence text="Acetaminophen (APAP) is a widely used analgesic drug that is frequently co-administered with caffeine (CAF) in the treatment of pain"><entity charOffset="0-13" id="DDI-PubMed.28130915.s2.e0" text="Acetaminophen" /><entity charOffset="15-19" id="DDI-PubMed.28130915.s2.e1" text="APAP" /><entity charOffset="93-101" id="DDI-PubMed.28130915.s2.e2" text="caffeine" /><entity charOffset="103-106" id="DDI-PubMed.28130915.s2.e3" text="CAF" /><pair ddi="false" e1="DDI-PubMed.28130915.s2.e0" e2="DDI-PubMed.28130915.s2.e0" /><pair ddi="false" e1="DDI-PubMed.28130915.s2.e0" e2="DDI-PubMed.28130915.s2.e1" /><pair ddi="false" e1="DDI-PubMed.28130915.s2.e0" e2="DDI-PubMed.28130915.s2.e2" /><pair ddi="false" e1="DDI-PubMed.28130915.s2.e0" e2="DDI-PubMed.28130915.s2.e3" /><pair ddi="false" e1="DDI-PubMed.28130915.s2.e1" e2="DDI-PubMed.28130915.s2.e1" /><pair ddi="false" e1="DDI-PubMed.28130915.s2.e1" e2="DDI-PubMed.28130915.s2.e2" /><pair ddi="false" e1="DDI-PubMed.28130915.s2.e1" e2="DDI-PubMed.28130915.s2.e3" /><pair ddi="false" e1="DDI-PubMed.28130915.s2.e2" e2="DDI-PubMed.28130915.s2.e2" /><pair ddi="false" e1="DDI-PubMed.28130915.s2.e2" e2="DDI-PubMed.28130915.s2.e3" /></sentence><sentence text=" It is well known that APAP may cause severe liver injury after an acute overdose"><entity charOffset="23-25" id="DDI-PubMed.28130915.s3.e0" text="APAP" /></sentence><sentence text=" However, the understanding of whether and to what extent CAF inhibits or stimulates APAP-induced hepatotoxicity in humans is still lacking"><entity charOffset="85-88" id="DDI-PubMed.28130915.s4.e0" text="APAP" /><entity charOffset="58-61" id="DDI-PubMed.28130915.s4.e1" text="CAF" /><pair ddi="false" e1="DDI-PubMed.28130915.s4.e1" e2="DDI-PubMed.28130915.s4.e1" /><pair ddi="false" e1="DDI-PubMed.28130915.s4.e1" e2="DDI-PubMed.28130915.s4.e0" /></sentence><sentence text=" Here, a multiscale analysis is presented that quantitatively models the pharmacodynamic (PD) response of APAP during co-medication with CAF"><entity charOffset="106-108" id="DDI-PubMed.28130915.s5.e0" text="APAP" /><entity charOffset="137-139" id="DDI-PubMed.28130915.s5.e1" text="CAF" /><pair ddi="false" e1="DDI-PubMed.28130915.s5.e0" e2="DDI-PubMed.28130915.s5.e0" /><pair ddi="false" e1="DDI-PubMed.28130915.s5.e0" e2="DDI-PubMed.28130915.s5.e1" /></sentence><sentence text=" Therefore, drug-drug interaction (DDI) processes were integrated into physiologically based pharmacokinetic (PBPK) models at the organism level, whereas drug-specific PD response data were contextualized at the cellular level" /><sentence text=" The results provide new insights into the inhibitory and stimulatory effects of CAF on APAP-induced hepatotoxicity for crucially affected key cellular processes and individual genes at the patient level"><entity charOffset="88-90" id="DDI-PubMed.28130915.s7.e0" text="APAP" /><entity charOffset="81-83" id="DDI-PubMed.28130915.s7.e1" text="CAF" /><pair ddi="false" e1="DDI-PubMed.28130915.s7.e1" e2="DDI-PubMed.28130915.s7.e1" /><pair ddi="false" e1="DDI-PubMed.28130915.s7.e1" e2="DDI-PubMed.28130915.s7.e0" /></sentence><sentence text=" This study might facilitate the risk assessment of drug combination therapies in humans and thus may improve patient safety in clinical practice" /><sentence text="" /></document>